← Leaderboards
Emelia J. Benjamin
Boston University Medical Campus
$25,371,486
Attributed
$50,479,532
Total exposure
15
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,479,532 · 15
By mechanism
R01$47,068,431 · 12
P50$1,535,512 · 1
RC1$967,223 · 1
K12$908,366 · 1
Top collaborators
- Patrick Thomas Ellinor22 shared
- Robert R Edwards15 shared
- Tuhina Neogi15 shared
- Kathryn L Lunetta14 shared
- Mario Sims5 shared
- David D. Mcmanus4 shared
- Joanne M Murabito4 shared
- Lesley H Curtis3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Joanne M Murabito$6,997,824
- Subimal Datta$9,602,938
- Veronica M Vieira$5,420,787
- Vanessa Xanthakis$2,778,431
- Philip A Wolf$73,079,979
Others in their field
Top investigators on “Multidisciplinary”
- Lawrence Corey · Fred Hutchinson Cancer Center$298,997,339
- David Heimbrook · Leidos Biomedical Research, Inc.$251,484,793
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S. Currier · University Of California Los Angeles$188,628,043
- Barton F Haynes · Duke University$186,871,361
Research focus
MultidisciplinaryRisk FactorsCohortCommunitiesInnovationBaseAffectCardiovascular DiseasesFramingham Heart StudyResearch PersonnelGrantCessation Of LifeGeneticHeart FailureInsightVariantGenesCardiovascular SystemPrevalenceAmericanStrokeElderlyInternationalPhenotype
Grant awards (73)
Boston University BIRCWH$908,366
K12 · FY2025 · AR · contact PI
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$715,447
R01 · FY2025 · HL
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization$634,585
R01 · FY2025 · NS
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly$626,409
R01 · FY2025 · AG
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$706,324
R01 · FY2024 · HL
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization$620,064
R01 · FY2024 · NS
Pain in community-based older African American Adults: The Jackson Heart Study$618,925
R01 · FY2024 · AG
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$720,739
R01 · FY2023 · HL
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly$649,476
R01 · FY2023 · AG
Pain in community-based older African American Adults: The Jackson Heart Study$628,739
R01 · FY2023 · AG
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$756,989
R01 · FY2022 · HL
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly$657,736
R01 · FY2022 · AG
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization$655,993
R01 · FY2022 · NS
Pain in community-based older African American Adults: The Jackson Heart Study$638,428
R01 · FY2022 · AG
FHS-NEXT - Framingham Novel EXam using Technology$615,785
R01 · FY2022 · HL
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization$558,085
R01 · FY2022 · NS
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$801,920
R01 · FY2021 · HL
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization$684,920
R01 · FY2021 · NS
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly$670,589
R01 · FY2021 · AG
Pain in community-based older African American Adults: The Jackson Heart Study$652,346
R01 · FY2021 · AG
FHS-NEXT - Framingham Novel EXam using Technology$615,785
R01 · FY2021 · HL
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$801,920
R01 · FY2020 · HL
Pain in community-based older African American Adults: The Jackson Heart Study$702,564
R01 · FY2020 · AG
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly$697,663
R01 · FY2020 · AG
FHS-NEXT - Framingham Novel EXam using Technology$616,226
R01 · FY2020 · HL
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$805,220
R01 · FY2019 · HL
FHS-NEXT - Framingham Novel EXam using Technology$633,499
R01 · FY2019 · HL
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL$829,096
R01 · FY2018 · HL
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses$774,042
R01 · FY2018 · HL · contact PI
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$827,989
R01 · FY2017 · HL
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses$773,155
R01 · FY2017 · HL · contact PI
Research Training and Education Core (Core D)$365,697
P50 · FY2017 · HL · contact PI
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$834,434
R01 · FY2016 · HL
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses$761,571
R01 · FY2016 · HL · contact PI
Research Training and Education Core (Core D)$357,540
P50 · FY2016 · HL · contact PI
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$828,078
R01 · FY2015 · HL
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses$772,406
R01 · FY2015 · HL · contact PI
Research Training and Education Core (Core D)$350,841
P50 · FY2015 · HL · contact PI
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$6,965,761
R01 · FY2014 · HL
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$829,831
R01 · FY2014 · HL
Research Training and Education Core (Core D)$342,609
P50 · FY2014 · HL · contact PI
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval$829,164
R01 · FY2013 · HL
Research Training and Education Core (Core D)$118,825
P50 · FY2013 · HL · contact PI
Identification of common genetic variants for atrial fibrillation and PR interval$817,670
R01 · FY2012 · HL · contact PI
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$438,684
R01 · FY2012 · HL
Identification of common genetic variants for atrial fibrillation and PR interval$815,994
R01 · FY2011 · HL · contact PI
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$468,765
R01 · FY2011 · HL
Identification of common genetic variants for atrial fibrillation and PR interval$811,807
R01 · FY2010 · HL · contact PI
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$493,621
R01 · FY2010 · HL
Risk prediction of atrial fibrillation: clinical, biological and genetic markers$474,529
RC1 · FY2010 · HL · contact PI
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study$343,012
R01 · FY2010 · AG · contact PI
Identification of common genetic variants for atrial fibrillation and PR interval$861,837
R01 · FY2009 · HL · contact PI
Risk prediction of atrial fibrillation: clinical, biological and genetic markers$492,694
RC1 · FY2009 · HL · contact PI
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study$349,851
R01 · FY2009 · AG · contact PI
Framingham: Inflammation, Genes & Cardiovascular Disease$771,807
R01 · FY2008 · HL · contact PI
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study$351,330
R01 · FY2008 · AG · contact PI
Framingham: Inflammation, Genes & Cardiovascular Disease$787,498
R01 · FY2007 · HL · contact PI
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study$353,815
R01 · FY2007 · AG · contact PI
Framingham: Inflammation, Genes & Cardiovascular Disease$777,030
R01 · FY2006 · HL · contact PI
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study$363,035
R01 · FY2006 · AG · contact PI
Framingham: Inflammation, Genes &Cardiovascular Disease$802,666
R01 · FY2005 · HL
Vascular Function in the Framingham Third Generation$503,105
R01 · FY2005 · HL
Framingham: Inflammation, Genes &Cardiovascular Disease$802,013
R01 · FY2004 · HL
Vascular Function in the Framingham Third Generation$602,840
R01 · FY2004 · HL
Vascular Function in the Framingham Third Generation$589,624
R01 · FY2003 · HL
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM$192,560
R01 · FY2003 · HL
Vascular Function in the Framingham Third Generation$701,043
R01 · FY2002 · HL
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM$325,602
R01 · FY2002 · HL
ENDOTHELIAL VASAMOTOR FUNCTION IN THE FRAMINGHAM STUDY$136,099
R01 · FY2002 · HL
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM$316,850
R01 · FY2001 · HL
ENDOTHELIAL VASAMOTOR FUNCTION IN THE FRAMINGHAM STUDY$233,299
R01 · FY2001 · HL
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM$319,383
R01 · FY2000 · HL
ENDOTHELIAL VASAMOTOR FUNCTION IN THE FRAMINGHAM STUDY$225,688
R01 · FY2000 · HL